BioSpace News Archive

StemSation International, Inc. (OTC Pink: STSN) – a pioneer in the emerging category of dietary supplements called Stem Cell Nutrition, announces its second product, a fast-acting and exclusive formula named ProStem PSP™ for joint and muscle health

ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, has announced the finalization of national agreements with top German Statutory Health Insurers (“SHI”) Techniker Krankenkasse (“TK”) and Deutsche Angestellten-Krankenkasse – Gesundheit (“DAK-Gesundheit”).

The ProPath Immunohistochemistry (IHC) division is one of the most sophisticated specialty laboratories in the country.

Monteris Medical, a pioneer and leader in the market for minimally invasive, image-guided laser ablation systems, announced today that results from a multicenter clinical study of its NeuroBlate® System have been published in the peer-reviewed journal Neurosurgery

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 30 million members nationally, has named Kyle Skiermont, PharmD, as senior vice president, specialty pharmacy and home delivery services.

Nanovis today announced that it received 510(k) clearance for a bioceramic nanotube surface on its Nano FortiFix Pedicle Screw System.

Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today unveiled a new brand identity, website, and logo which reflect the company’s collective learning and evolution since it was launched in 2012, and set in motion “The Click Way,” the company’s mission, core values and blueprint for growth.

Biomarck Pharmaceuticals, Ltd., a biopharmaceutical company developing targeted anti-MARCKS technology for the treatment of ARDS [Acute Respiratory Distress Syndrome], cancer and other difficult to treat diseases, today announced results of a Phase 2a clinical study for patients with ARDS.

iBIO, the Illinois Biotechnology Innovation Organization, today announced a summary of the iBIO COVID-19 PPE Response Fund’s impact since its March 23 launch.

In response to the pressing need for more COVID-19 testing, Stratasys, Inc. and Origin have signed an agreement in which Stratasys will market and promote Origin 3D-printed nasopharyngeal (NP) swabs to healthcare providers and other testing centers in the U.S.